COVID-19 Vaccination

Supply Constraints Ease in U.S. Vaccine Rollout

As the U.S. vaccination campaign progresses, President Biden has moved up the timeline for states to make every American adult eligible for COVID-19 vaccination. States now have until April 19 to open up vaccines to everyone over the age of 16, following the lead of Alaska, the first state to drop eligibility requirements as early as March 10.

As supply constraints continue to ease, the challenge ahead is expected to shift from getting vaccine doses produced and delivered to convincing people of getting jabbed and ensuring a smooth rollout of the available doses. In his statement, the president once again urged Americans to remain careful for the time being, saying that the end of the pandemic may be in sight, but “we aren’t at the finish line” just yet. Reiterating his goal of celebrating July 4 without major restrictions, “the real question is: How much death, disease, and misery are we going to see between now and then?” Biden said.

According to CDC data tracked and compiled by data scientist Conor Kelly, the number of vaccine doses delivered to provider locations has continuously outstripped the number of doses administered since late February, resulting in a growing stock of doses ready to be administered. As of April 13, 6:00am ET, the number of available doses has grown to 53.1 million, with 245.4 million doses delivered and 192.3 million doses administered to more than 120 million Americans.

Description

This chart shows the total number of COVID-19 vaccine doses distributed and administered in the United States.

Download Chart
Premium statistics
Import value of vaccines for human medicine Philippines 2012-2023
Premium statistics
Export value of vaccines for human medicine Philippines 2012-2023
Premium statistics
Import value of vaccines for human medicine Singapore 2022, by country
Leading vaccines and antisera dispensed in England 2023, by item number
Premium statistics
Export value of vaccines for human medicine Singapore 2021, by destination country
Premium statistics
Import value of vaccines for human medicine Singapore 2012-2021

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Do you still have questions?

Feel free to contact us anytime using our contact form or visit our FAQ page.

Statista Content & Design

Need infographics, animated videos, presentations, data research or social media charts?

More Information